Biology subjects

Bierle, C. J.

Publications and source records attributed to Bierle, C. J..

9 recordsLinked to original sources

bioRxiv2026

Classical guinea pig coat phenotypes are associated with variants in FGF5 and CELSR1

Classical Mendelian coat phenotypes in the domestic guinea pig, Cavia porcellus, were central to early studies of mammalian genetics, yet their molecular bases remain unresolved. Long fur is characterized by elongated hair, and rough coat by whorled patterns of fur orientation. Here, we performed genome-wide association mapping using exome and whole-genome sequencing data to identify the genetic basis of both phenotypes. Mapping of long fur identified a locus containing FGF5 and resolved the association to a premature stop codon, independently confirming a previously proposed candidate variant. Mapping of rough coat identified a locus containing CELSR1, an atypical cadherin and core component of the planar cell polarity (PCP) pathway, resolving the association to an in-frame proline insertion in its extracellular domain. The variant is associated with a dominant rough-coat phenotype, unlike previously characterized recessive mouse Celsr1 alleles, which produce a similar hair-patterning phenotype only when homozygous. The mouse alleles are also associated with severe developmental abnormalities, including open neural tube, which are not observed in rough-coat guinea pigs. This dominant, tissue-specific phenotype suggests that the insertion alters CELSR1 function in a previously undescribed manner. Consistent with this possibility, the rough-coat variant localized normally to cell-cell junctions in cultured mouse keratinocytes and retained its ability to recruit Fzd6 and Vangl2, demonstrating preserved molecular interactions involved in PCP junction assembly. These findings resolve the molecular basis of two classical guinea pig coat phenotypes and identify a naturally occurring, dominant CELSR1 allele associated with a mode of PCP disruption distinct from previously characterized alleles.

genetics↗

bioRxiv2026

Pichinde virus models intrauterine infection by hemorrhagic fever-causing arenaviruses

Arenavirus infection during pregnancy can cause severe maternal disease, congenital infection, and fetal demise. Many arenaviruses are endemic in economically disadvantaged areas and must be studied in high containment laboratories, which has limited our understanding of arenavirus pathogenesis in the placenta. Pichinde virus (PICV) is a nonpathogenic arenavirus that recapitulates many aspects of viral hemorrhagic fever in guinea pigs. Using a combination of experiments in human placental cells and guinea pigs, we characterized the tropism and impact of PICV infection during pregnancy. PICV replicated in human trophoblast stem cells (TSCs), TSC-derived trophoblasts, and explanted term placenta. When guinea pigs were infected at mid-gestation, PICV caused fetal demise. High infectious titers were recovered from placenta and decidua, but PICV was infrequently detected in fetal tissues or amniotic fluid. In situ hybridization confirmed that the placenta, decidua, and fetal membranes were all infected by the virus. Transcriptional profiling of PICV-infected human trophoblasts and guinea pig tissues revealed that infection upregulated canonical antiviral responses, which could contribute to placental dysfunction and pregnancy loss. Thus, PICV is safe and tractable model of zoonotic arenavirus infection during pregnancy with utility for preclinical therapeutic and vaccine development.

microbiology↗

bioRxiv2025

Spatial Transcriptomics Reveals that the Local Immune Response to Placental Guinea Pig

Cytomegalovirus infection can disrupt placental development and function either by directly infecting placental cells or by eliciting a pathogenic immune response. The relative contributions of these two mechanisms to adverse pregnancy outcomes remains poorly understood. In this study, we used spatial transcriptomics to quantify host and viral gene expression at the maternal-fetal interface at near single-cell resolution. Guinea pig cytomegalovirus (GPCMV) infection after mid-gestation causes focal infections at the base of the main placenta. Samples for spatial transcriptomics were collected from guinea pigs infected with GPCMV at 35 days gestation. Viral loads and the location of infected cells in placentas were assessed using virus-specific droplet digital PCR and in situ hybridization at 21 days post-infection. Representative placentas were sectioned onto Visium Spatial Gene Expression Slides and sequencing libraries were prepared from six infected and six uninfected tissue sections. Spatial transcriptomes from 33,687 55-{micro}m spots were generated and used in subsequent analyses. To assess how infection affected gene expression at the maternal-fetal interface, a combination of graph-based clustering and manual classification was used to assign spatial transcriptomes to clusters representative of different anatomic regions. Infection dysregulated more transcripts in the decidua and junctional zone than in the labyrinth or non-capillarized syncytium. Notably, infection downregulated transcripts involved in lipid metabolism and upregulated transcripts involved in antiviral defense and chemokine signaling. A second analysis compared the spatial transcriptomes of GPCMV-infected cells and their immediate microenvironment with similar regions in uninfected placentas. A transcriptional signature indicative of immune activation was clear in this comparison, and the local placental response to cytomegalovirus infection was driven by upregulated chemokine signaling. Thus, spatial transcriptomics revealed regional patterns of gene expression in the guinea pig placenta and illuminated how the host response to GPCMV may compromise placental function. Author SummaryThe placenta supports fetal development while also acting as an immune barrier against bloodborne pathogens. Cytomegalovirus (CMV), the most common viral cause of congenital infections and preventable neurologic disability in children, evades host defenses to infect the placenta. How CMV affects the placenta and fetal health remains poorly understood. Using a guinea pig model of CMV infection during pregnancy and spatial transcriptomics, a recently-developed method that enables gene expression to be studied at near-cellular resolution, this study compared normal and infected placentas. The effects of infection on directly infected cells and their immediate environment and indirect effects that occur at more distant sites were revealed. This information may inform the development of therapies to improve placental function after CMV infection.

immunology↗

bioRxiv2025

Replication-Deficient Whole-Virus Vaccines Against Cytomegalovirus Induce Protective Immunity in a Guinea Pig Congenital Infection Model

Vaccines are needed to prevent congenital cytomegalovirus (CMV) infections. This study used the guinea pig cytomegalovirus (GPCMV) model to examine replication-deficient whole-virus vaccines against maternal viremia and congenital infection. Two recombinant GPCMVs, GP51-DD and GP52-DD, were engineered with destabilization domains fused to essential viral late proteins GP51 and GP52. These viruses, predicted to replicate in the presence of the synthetic ligand Shield-1 but not in its absence, were evaluated for Shield-1-dependence in vitro and for safety, immunogenicity, and efficacy in a pregnancy/challenge model. GP52-DD was profoundly Shield-1-dependent, producing no detectable infectious progeny in its absence. In contrast, the replication of GP51-DD was delayed in the absence of Shield-1, but the virus reached similar peak titers with or without the compound. GPCMV-seronegative guinea pigs received two subcutaneous injections of placebo (sham-immunized), GP51-DD, GP52-DD, or wild-type GPCMV (WT-GPCMV). DNAemia post-vaccination was detected in only one of 14 dams in each of the GP51-DD- and GP52-DD-immunized groups compared to 10/10 control animals immunized with WT-GPCMV, confirming the recombinant viruses were attenuated. GPCMV-specific antibody responses were similar in all three vaccinated groups. When immunized dams were bred and challenged with virulent GPCMV, DNAemia was detected in all sham-immunized controls and in 44% of GP52-DD-immunized dams (at significantly reduced levels) but was absent in dams immunized with GP51-DD or WT-GPCMV. Notably, immunization with GP52-DD, GP51-DD, or WT-GPCMV significantly reduced congenital GPCMV transmission (protective efficacies of 89%, 94%, and 100%, respectively). Thus, the replication-deficient GP52-DD vaccine was attenuated and protected against intrauterine GPCMV transmission. ImportanceCongenital cytomegalovirus (CMV) infections could be prevented by a vaccine, but most of the vaccine designs that have advanced to clinical trials have been subunit vaccines. These viral envelope glycoprotein-targeting designs have not yielded an effective vaccine that provides durable immunity. A vaccine that confers immune responses to a broader repertoire of viral immunogens, such as vaccines based on the whole virus, could enhance protection. However, there are concerns about the safety of live attenuated CMV vaccines. Using the guinea pig/guinea pig cytomegalovirus model of congenital infection, this study demonstrates that two replication-deficient whole virus vaccines are attenuated in animals while also being highly immunogenic, providing protective immunity against maternal viremia and fetal infection at levels similar to that conferred by a wild-type virus.

immunology↗

bioRxiv2024

CD4+ but not CD8+ T cells are required for protection against severe guinea pig cytomegalovirus infections

Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus and the leading cause of infectious disease related birth defects worldwide. How the immune response modulates the risk of intrauterine transmission of HCMV after maternal infection remains poorly understood. Maternal T cells likely play a critical role in preventing infection at the maternal-fetal interface and limiting spread across the placenta, but concerns exist that immune responses to infection may also cause placental dysfunction and adverse pregnancy outcomes. This study investigated the role of CD4+ and CD8+ T cells in a guinea pig model of primary cytomegalovirus infection. Monoclonal antibodies specific to guinea pig CD4 and CD8 were used to deplete T cells in non- pregnant and in pregnant guinea pigs after mid-gestation. CD4+ T cell depletion increased the severity of illness, caused significantly elevated viral loads, and increased the rate of congenital guinea pig cytomegalovirus (GPCMV) infection relative to animals treated with control antibody. CD8+ T cell depletion was comparably well tolerated and did not significantly affect the weight of infected guinea pigs or viral loads in their blood or tissue. However, significantly more viral genomes and transcripts were detected in the placenta and decidua of CD8+ T cell depleted dams post-infection. This study corroborates earlier findings made in nonhuman primates that maternal CD4+ T cells play a critical role in limiting the severity of primary CMV infection during pregnancy while also revealing that other innate and adaptive immune responses can compensate for an absent CD8+ T cell response in -CD8-treated guinea pigs. Author SummaryCongenital cytomegalovirus infection is a leading cause of adverse pregnancy outcomes and preventable disability in children. Using guinea pigs, a well-established small animal model of congenital infection and intrauterine development, this study tested how depleting T cells affects the course of primary cytomegalovirus infections. Severe illness and high rates of congenital infection were observed when helper CD4+ T cells were depleted. The depletion of killer CD8+ T cells did not affect the severity of disease or the rate of congenital infection but did increase the amount of virus that was detected in the placenta. A greater understanding how an immune response can prevent the infection of the placenta and developing offspring is needed to inform vaccine and therapeutic development. This study not only describes a new reagent that can be used to study the guinea pig immune system but also sheds new light in how adaptive immunity regulates congenital viral infection.

immunology↗

bioRxiv2023

Human Trophoblast Stem Cells Restrict Human Cytomegalovirus Replication

Placental infection plays a central role in the pathogenesis of congenital human cytomegalovirus (HCMV) infections and is a cause of fetal growth restriction and pregnancy loss. HCMV can replicate in some trophoblast cell types, but it remains unclear how the virus evades antiviral immunity in the placenta and how infection compromises placental development and function. Human trophoblast stem cells (TSCs) can be differentiated into extravillous trophoblasts (EVTs), syncytiotrophoblasts (STBs), and organoids, and this study assessed the utility of TSCs as a model of HCMV infection in the first trimester placenta. HCMV was found to non-productively infect TSCs, EVTs, and STBs. Immunofluorescence assays and flow cytometry experiments further revealed that infected TSCs frequently only express immediate early viral gene products. Similarly, RNA-sequencing found that viral gene expression in TSCs does not follow the kinetic patterns observed during lytic infection in fibroblasts. Canonical antiviral responses were largely not observed in HCMV-infected TSCs and TSC-derived trophoblasts. Rather, infection dysregulated factors involved in cell identity, differentiation, and WNT signaling. Thus, while HCMV does not replicate in TSCs, infection may perturb trophoblast differentiation in ways that could interfere with placental function. ImportancePlacental infection plays a central role in HCMV pathogenesis during pregnancy, but the species-specificity of HCMV and the limited availability and lifespan of primary trophoblasts have been persistent barriers to understanding how infection impacts this vital organ. Human TSCs represent a new approach to modeling viral infection early in placental development. This study reveals that TSCs, like other stem cell types, restrict HCMV replication. However, infection perturbs the expression of genes involved in differentiation and cell fate determination, pointing to a mechanism by which HCMV could cause placental injury.

microbiology↗

bioRxiv2023

Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism

The APOBEC3 family of DNA cytosine deaminases comprises an important arm of the innate antiviral defense system. The gamma-herpesviruses EBV and KSHV and the alpha-herpesviruses HSV-1 and HSV-2 have evolved an efficient mechanism to avoid APOBEC3 restriction by directly binding to APOBEC3B and facilitating its exclusion from the nuclear compartment. The only viral protein required for APOBEC3B relocalization is the large subunit of the ribonucleotide reductase (RNR). Here, we ask whether this APOBEC3B relocalization mechanism is conserved with the beta-herpesvirus human cytomegalovirus (HCMV). Although HCMV infection causes APOBEC3B relocalization from the nucleus to the cytoplasm in multiple cell types, the viral RNR (UL45) is not required. APOBEC3B relocalization occurs rapidly following infection suggesting involvement of an immediate early or early (IE-E) viral protein. In support of this mechanism, cycloheximide treatment of HCMV-infected cells prevents the expression of viral proteins and simultaneously blocks APOBEC3B relocalization. In comparison, the treatment of infected cells with phosphonoacetic acid, which is a viral DNA synthesis inhibitor affecting late protein expression, still permits A3B relocalization. These results combine to show that the beta-herpesvirus HCMV uses a fundamentally different, RNR-independent molecular mechanism to antagonize APOBEC3B. ImportanceHuman cytomegalovirus (HCMV) infections can range from asymptomatic to severe, particularly in neonates and immunocompromised patients. HCMV has evolved strategies to overcome host-encoded antiviral defenses in order to achieve lytic viral DNA replication and dissemination and, under some conditions, latency and long-term persistence. Here, we show that HCMV infection causes the antiviral factor, APOBEC3B, to relocalize from the nuclear compartment to the cytoplasm. This overall strategy resembles that used by related herpesviruses. However, the HCMV relocalization mechanism utilizes a different viral factor(s) and available evidence suggests the involvement of at least one protein expressed at the early stages of infection. This knowledge is important because a greater understanding of this mechanism could lead to novel antiviral strategies that enable APOBEC3B to naturally restrict HCMV infection.

microbiology↗

bioRxiv2020

Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells

Zika virus (ZIKV) exhibits a tropism for brain tumor cells and has been used as an oncolytic virus to target brain tumors in mice with modest effects on extending median survival. Recent studies have highlighted the potential for combining virotherapy and immunotherapy to target cancer. We postulated that ZIKV could be used as an adjuvant to enhance the long-term survival of mice with malignant glioblastoma and generate memory T-cells capable of providing long-term immunity against cancer remission. To test this hypothesis mice bearing malignant intracranial GL261 tumors were subcutaneously vaccinated with irradiated GL261 cells previously infected with the ZIKV. Mice also received intracranial injections of live ZIKV, irradiated ZIKV, or irradiated GL261 cells previously infected with ZIKV. Long-term survivors were rechallenged with a second intracranial tumor to examine their immune response and look for the establishment of protective memory T-cells. Mice with subcutaneous vaccination plus intracranial irradiated ZIKV or intracranial irradiated GL261 cells previously infected with ZIKV exhibited the greatest extensions to overall survival. Flow cytometry analysis of immune cells within the brains of long-term surviving mice after tumor rechallenge revealed an upregulation in the levels of T-cells, including CD4+ and tissue-resident memory CD4+ T-cells, in comparison to long-term survivors that were mock-rechallenged, and in comparison to naive untreated mice challenged with intracranial gliomas. These results suggest that ZIKV can serve as an adjuvant to subcutaneous tumor vaccines that enhance long-term survival and generate protective tissue-resident memory CD4+ T-cells.

cancer biology↗

bioRxiv2019

A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits

An integral part of the antiviral innate immune response is the APOBEC3 family of single-stranded DNA cytosine deaminases, which inhibits virus replication through deamination-dependent and -independent activities. Viruses have evolved mechanisms to counteract these enzymes such as HIV-1 Vif-mediated formation of a ubiquitin ligase to degrade virus-restrictive APOBEC3 enzymes. A new example is Epstein-Barr virus (EBV) ribonucleotide reductase (RNR)-mediated inhibition of cellular APOBEC3B (A3B). The large subunit of the viral RNR, BORF2, causes A3B relocalization from the nucleus to cytoplasmic bodies and thereby protects viral DNA during lytic replication. Here, we use co-immunoprecipitation and immunofluorescent microscopy approaches to ask whether this mechanism is shared with the closely related {gamma}-herpesvirus Kaposis sarcoma-associated herpesvirus (KSHV) and the more distantly related -herpesvirus, herpes simplex virus-1 (HSV-1). The large RNR subunit of KSHV, ORF61, co-precipitated multiple APOBEC3s including A3B and APOBEC3A (A3A). KSHV ORF61 also caused relocalization of these two enzymes to perinuclear bodies (A3B) and to oblong cytoplasmic structures (A3A). The large RNR subunit of HSV-1, ICP6, also co-precipitated A3B and A3A and was sufficient to promote the relocalization of these enzymes from nuclear to cytoplasmic compartments. HSV-1 infection caused similar relocalization phenotypes that required ICP6. However, unlike the infectivity defects previously reported for BORF2-null EBV, ICP6 mutant HSV-1 showed normal growth rates and plaque phenotypes. These results combine to indicate that both {gamma}- and -herpesviruses use a conserved RNR-dependent mechanism to relocalize A3B and A3A and, further, suggest that HSV-1 possesses at least one additional mechanism to neutralize these antiviral enzymes.\n\nImportanceThe APOBEC3 family of DNA cytosine deaminases constitutes a vital innate immune defense against a range of different viruses. A novel counter-restriction mechanism has recently been uncovered for the {gamma}-herpesvirus EBV, in which a subunit of the viral protein known to produce DNA building blocks (ribonucleotide reductase) causes A3B to relocalize from the nucleus to the cytosol. Here, we extend these observations with A3B to include a closely related {gamma}-herpesvirus, KSHV, and to a more distantly related -herpesvirus, HSV-1. These different viral ribonucleotide reductases also caused relocalization of A3A, which is 92% identical to A3B. These studies are important because they suggest a conserved mechanism of APOBEC3 evasion by large double-stranded DNA herpesviruses. Strategies to block this host-pathogen interaction may be effective for treating infections caused by these herpesviruses.

microbiology↗